The efficacy of antifibrinolytic drugs in children undergoing noncardiac surgery: A systematic review of the literature

Anesthesia and Analgesia

Volumn 118, Issue 3, 2014, Pages 628-636

  Faraoni, David ^a   Goobie, Susan M ^b  

^a HOP UNIV DES ENFANTS REINE FABIOLA   (Belgium)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; APROTININ; PLASMIN; PLASMINOGEN; TRANEXAMIC ACID;

BLEEDING; BLOOD TRANSFUSION; CRANIOFACIAL SURGERY; DRUG EFFICACY; FIBRINOLYSIS; HUMAN; NONCARDIAC SURGERY; PEDIATRIC SURGERY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCOLIOSIS; SPINE SURGERY; SURGERY; SYSTEMATIC REVIEW;

ANTIFIBRINOLYTIC AGENTS; CHILD; HUMANS; ORTHOPEDIC PROCEDURES; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84894664135     PISSN: 00032999     EISSN: 15267598     Source Type: Journal    
DOI: 10.1213/ANE.0000000000000080     Document Type: Review

References (57)

1. Cardone D, Klein AA. Perioperative blood conservation. Eur J Anaesthesiol 2009;26:722-9
2. Despotis GJ, Gravlee G, Filos K, Levy J. Anticoagulation monitoring during cardiac surgery: A review of current and emerging techniques. Anesthesiology 1999;91:1122-51
3. Cesarman-Maus G, Hajjar KA. Molecular mechanisms of fibrinolysis. Br J Haematol 2005;129:307-21
4. Medcalf RL. Fibrinolysis, inflammation, and regulation of the plasminogen activating system. J Thromb Haemost 2007;5 Suppl 1:132-42
5. Levy JH. Antifibrinolytic therapy: New data and new concepts. Lancet 2010;376:3-4
6. Schouten ES, van De Pol AC, Schouten AN, Turner NM, Jansen NJ, Bollen CW. The effect of aprotinin, tranexamic acid, and aminocaproic acid on blood loss and use of blood products in major pediatric surgery: A meta-Analysis. Pediatr Crit Care Med 2009;10:182-90
7. McCarthy MW, Coley KC. Aprotinin for prophylaxis of blood loss. Ann Pharmacother 1994;28:1246-8
8. Mangano DT, Tudor IC, Dietzel C; Multicenter Study of Perioperative Ischemia Research Group; Ischemia Research and Education Foundation. The risk associated with aprotinin in cardiac surgery. N Engl J Med 2006;354:353-65
9. Fergusson DA, Hébert PC, Mazer CD, Fremes S, MacAdams C, Murkin JM, Teoh K, Duke PC, Arellano R, Blajchman MA, Bussières JS, Côté D, Karski J, Martineau R, Robblee JA, Rodger M, Wells G, Clinch J, Pretorius R; BART Investigators. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 2008;358:2319-31
10. Mannucci PM, Levi M. Prevention and treatment of major blood loss. N Engl J Med 2007;356:2301-11
11. Ngaage DL, Bland JM. Lessons from aprotinin: Is the routine use and inconsistent dosing of tranexamic acid prudent? Metaanalysis of randomised and large matched observational studies. Eur J Cardiothorac Surg 2010;37:1375-83
12. Zufferey P, Merquiol F, Laporte S, Decousus H, Mismetti P, Auboyer C, Samama CM, Molliex S. Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery? Anesthesiology 2006;105:1034-46
13. Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y, El-Sayed H, Gogichaishvili T, Gupta S, Herrera J, Hunt B, Iribhogbe P, Izurieta M, Khamis H, Komolafe E, Marrero MA, Mejia-Mantilla J, Miranda J, Morales C, Olaomi O, Olldashi F, Perel P, Peto R, Ramana PV, Ravi RR, Yutthakasemsunt S. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): A randomised, placebo-controlled trial. Lancet 2010;376:23-32
14. Eaton MP. Antifibrinolytic therapy in surgery for congenital heart disease. Anesth Analg 2008;106:1087-100
15. Faraoni D, Willems A, Melot C, De Hert S, Van Der Linden P. Efficacy of tranexamic acid in paediatric cardiac surgery: A systematic review and meta-Analysis. Eur J Cardiothorac Surg 2012;42:781-6
16. Osthaus WA, Boethig D, Johanning K, Rahe-Meyer N, Theilmeier G, Breymann T, Suempelmann R. Whole blood coagulation measured by modified thrombelastography (ROTEM) is impaired in infants with congenital heart diseases. Blood Coagul Fibrinolysis 2008;19:220-5
17. Hresko MT. Clinical practice. Idiopathic scoliosis in adolescents. N Engl J Med 2013;368:834-41
18. Brenn BR, Theroux MC, Dabney KW, Miller F. Clotting parameters and thromboelastography in children with neuromuscular and idiopathic scoliosis undergoing posterior spinal fusion. Spine (Phila Pa 1976) 2004;29:E310-4
19. Bird S, McGill N. Blood conservation and pain control in scoliosis corrective surgery: An online survey of UK practice. Paediatr Anaesth 2011;21:50-3
20. Florentino-Pineda I, Blakemore LC, Thompson GH, Poe-Kochert C, Adler P, Tripi P. The Effect of epsilon-Aminocaproic acid on perioperative blood loss in patients with idiopathic scoliosis undergoing posterior spinal fusion: A preliminary prospective study. Spine (Phila Pa 1976) 2001;26:1147-51
21. Florentino-Pineda I, Thompson GH, Poe-Kochert C, Huang RP, Haber LL, Blakemore LC. The effect of amicar on perioperative blood loss in idiopathic scoliosis: The results of a prospective, randomized double-blind study. Spine (Phila Pa 1976) 2004;29:233-8
22. Thompson GH, Florentino-Pineda I, Poe-Kochert C. The role of amicar in decreasing perioperative blood loss in idiopathic scoliosis. Spine (Phila Pa 1976) 2005;30:S94-9
23. Thompson GH, Florentino-Pineda I, Poe-Kochert C, Armstrong DG, Son-Hing J. Role of Amicar in surgery for neuromuscular scoliosis. Spine (Phila Pa 1976) 2008;33:2623-9
24. Thompson GH, Florentino-Pineda I, Poe-Kochert C, Armstrong DG, Son-Hing JP. The role of Amicar in same-day anterior and posterior spinal fusion for idiopathic scoliosis. Spine (Phila Pa 1976) 2008;33:2237-42
25. Neilipovitz DT, Murto K, Hall L, Barrowman NJ, Splinter WM. A randomized trial of tranexamic acid to reduce blood transfusion for scoliosis surgery. Anesth Analg 2001;93:82-7
26. Sethna NF, Zurakowski D, Brustowicz RM, Bacsik J, Sullivan LJ, Shapiro F. Tranexamic acid reduces intraoperative blood loss in pediatric patients undergoing scoliosis surgery. Anesthesiology 2005;102:727-32
27. Shapiro F, Zurakowski D, Sethna NF. Tranexamic acid diminishes intraoperative blood loss and transfusion in spinal fusions for duchenne muscular dystrophy scoliosis. Spine (Phila Pa 1976) 2007;32:2278-83
28. Grant JA, Howard J, Luntley J, Harder J, Aleissa S, Parsons D. Perioperative blood transfusion requirements in pediatric scoliosis surgery: The efficacy of tranexamic acid. J Pediatr Orthop 2009;29:300-4
29. Dhawale AA, Shah SA, Sponseller PD, Bastrom T, Neiss G, Yorgova P, Newton PO, Yaszay B, Abel MF, Shufflebarger H, Gabos PG, Dabney KW, Miller F. Are antifibrinolytics helpful in decreasing blood loss and transfusions during spinal fusion surgery in children with cerebral palsy scoliosis? Spine (Phila Pa 1976) 2012;37:E549-55
30. Yagi M, Hasegawa J, Nagoshi N, Iizuka S, Kaneko S, Fukuda K, Takemitsu M, Shioda M, Machida M. Does the intraoperative tranexamic acid decrease operative blood loss during posterior spinal fusion for treatment of adolescent idiopathic scoliosis? Spine (Phila Pa 1976) 2012;37:E1336-42
31. Newton PO, Bastrom TP, Emans JB, Shah SA, Shufflebarger HL, Sponseller PD, Sucato DJ, Lenke LG. Antifibrinolytic agents reduce blood loss during pediatric vertebral column resection procedures. Spine (Phila Pa 1976) 2012;37:E1459-63
32. Xu C, Wu A, Yue Y. Which is more effective in adolescent idiopathic scoliosis surgery: Batroxobin, tranexamic acid or a combination? Arch Orthop Trauma Surg 2012;132:25-31
33. Dadure C, Sauter M, Bringuier S, Bigorre M, Raux O, Rochette A, Canaud N, Capdevila X. Intraoperative tranexamic acid reduces blood transfusion in children undergoing craniosynostosis surgery: A randomized double-blind study. Anesthesiology 2011;114:856-61
34. Goobie SM, Meier PM, Pereira LM, McGowan FX, Prescilla RP, Scharp LA, Rogers GF, Proctor MR, Meara JG, Soriano SG, Zurakowski D, Sethna NF. Efficacy of tranexamic acid in pediatric craniosynostosis surgery: A double-blind, placebo-controlled trial. Anesthesiology 2011;114:862-71
35. Pirkle H. Thrombin-like enzymes from snake venoms: An updated inventory. Scientific and Standardization Committee's Registry of Exogenous Hemostatic Factors. Thromb Haemost 1998;79:675-83
36. Martin K, Breuer T, Gertler R, Hapfelmeier A, Schreiber C, Lange R, Hess J, Wiesner G. Tranexamic acid versus ?-Aminocaproic acid: Efficacy and safety in paediatric cardiac surgery. Eur J Cardiothorac Surg 2011;39:892-7
37. Tzortzopoulou A, Cepeda MS, Schumann R, Carr DB. Antifibrinolytic agents for reducing blood loss in scoliosis surgery in children. Cochrane Database Syst Rev 2008:CD006883
38. Yang B, Li H, Wang D, He X, Zhang C, Yang P. Systematic review and meta-Analysis of perioperative intravenous tranexamic acid use in spinal surgery. PLoS One 2013;8:e55436
39. Cohen MM Jr. Craniosynostosis and syndromes with craniosynostosis: Incidence, genetics, penetrance, variability, and new syndrome updating. Birth Defects Orig Artic Ser 1979;15:13-63
40. Czerwinski M, Hopper RA, Gruss J, Fearon JA. Major morbidity and mortality rates in craniofacial surgery: An analysis of 8101 major procedures. Plast Reconstr Surg 2010;126:181-6
41. Lavoie J. Blood transfusion risks and alternative strategies in pediatric patients. Paediatr Anaesth 2011;21:14-24
42. Pietrini D. Intraoperative management of blood loss during craniosynostosis surgery. Paediatr Anaesth 2013;23:278-80
43. Goobie S. The case for the use of tranexamic acid. Paediatr Anaesth 2013;23:281-4
44. Holcomb JB. Tranexamic acid in elective craniosynostosis surgery: It works, but how? Anesthesiology 2011;114:737-8
45. Goobie SM, Meier PM, Sethna NF, Soriano SG, Zurakowski D, Samant S, Pereira LM. Population pharmacokinetics of tranexamic acid in paediatric patients undergoing craniosynostosis surgery. Clin Pharmacokinet 2013;52:267-76
46. Stricker PA, Zuppa AF, Fiadjoe JE, Maxwell LG, Sussman EM, Pruitt EY, Goebel TK, Gastonguay MR, Taylor JA, Bartlett SP, Schreiner MS. Population pharmacokinetics of epsilon-Aminocaproic acid in infants undergoing craniofacial reconstruction surgery. Br J Anaesth 2013;110:788-99
47. Faraoni D, Hardy JF, Van Der Linden P. An early, multimodal, goal-directed approach of coagulopathy in the bleeding traumatized patient. Curr Opin Anaesthesiol 2013;26:193-5
48. Tauber H, Innerhofer P, Breitkopf R, Westermann I, Beer R, El Attal R, Strasak A, Mittermayr M. Prevalence and impact of abnormal ROTEM® assays in severe blunt trauma: Results of the 'Diagnosis and Treatment of Trauma-Induced Coagulopathy (DIA-TRE-TIC) study'. Br J Anaesth 2011;107:378-87
49. Theusinger OM, Wanner GA, Emmert MY, Billeter A, Eismon J, Seifert B, Simmen HP, Spahn DR, Baulig W. Hyperfibrinolysis diagnosed by rotational thromboelastometry (ROTEM) is associated with higher mortality in patients with severe trauma. Anesth Analg 2011;113:1003-12
50. Miner ME, Kaufman HH, Graham SH, Haar FH, Gildenberg PL. Disseminated intravascular coagulation fibrinolytic syndrome following head injury in children: Frequency and prognostic implications. J Pediatr 1982;100:687-91
51. Dalmau A, Sabaté A, Koo M, Rafecas A, Figueras J, Jaurrieta E. Prophylactic use of tranexamic acid and incidence of arterial thrombosis in liver transplantation. Anesth Analg 2001;93:516
52. Jain A, Costa G, Marsh W, Fontes P, Devera M, Mazariegos G, Reyes J, Patel K, Mohanka R, Gadomski M, Fung J, Marcos A. Thrombotic and nonthrombotic hepatic artery complications in adults and children following primary liver transplantation with long-Term follow-up in 1000 consecutive patients. Transpl Int 2006;19:27-37
53. Faraoni D, Goobie SM. New insights about the use of tranexamic acid in children undergoing cardiac surgery: From pharmacokinetics to pharmacodynamics. Anesth Analg 2013;117:760-2
54. Raza I, Davenport R, Rourke C, Platton S, Manson J, Spoors C, Khan S, De'Ath HD, Allard S, Hart DP, Pasi KJ, Hunt BJ, Stanworth S, MacCallum PK, Brohi K. The incidence and magnitude of fibrinolytic activation in trauma patients. J Thromb Haemost 2013;11:307-14
55. Jimenez JJ, Iribarren JL, Lorente L, Rodriguez JM, Hernandez D, Nassar I, Perez R, Brouard M, Milena A, Martinez R, Mora ML. Tranexamic acid attenuates inflammatory response in cardiopulmonary bypass surgery through blockade of fibrinolysis: A case control study followed by a randomized double-blind controlled trial. Crit Care 2007;11:R117
56. Weber CF, Görlinger K, Byhahn C, Moritz A, Hanke AA, Zacharowski K, Meininger D. Tranexamic acid partially improves platelet function in patients treated with dual antiplatelet therapy. Eur J Anaesthesiol 2011;28:57-62
57. Koster A, Börgermann J, Zittermann A, Lueth JU, Gillis-Januszewski T, Schirmer U. Moderate dosage of tranexamic acid during cardiac surgery with cardiopulmonary bypass and convulsive seizures: Incidence and clinical outcome. Br J Anaesth 2013;110:34-40